A recently recognized dementia that mimics many of the hallmarks of Alzheimer’s disease, but actually is an entirely different form of brain deterioration, has been documented in a new research paper.
Limbic-predominant age-related TDP-43 encephalopathy (also known as LATE) primarily affects adults 80 years and older and “has been associated with substantial cognitive impairment that mimicked Alzheimer’s disease,” said researchers of the paper, which appeared in the June edition of Brain: A Journal of Neurology. Continue reading
Would you want to know if you were at risk of Alzheimer’s disease, although it’s incurable and treatment options are limited?
Most people said yes” according to a recent survey from the Alliance for Aging Research conducted by Avalere Health. The vast majority of those surveyed also said that early detection is important to them and that they are willing to participate in clinical trials. Continue reading
Photo: Alan Kotok via FlickrActor Alan Alda is among an estimated 10 million people worldwide living with Parkinson’s disease.
Parkinson’s disease (PD) can be a devastating diagnosis, but most people can lead full, active lives for many years thanks to medications that can control common symptoms, as well as surgical options, speech and physical therapy and lifestyle changes.
Actor Alan Alda, 82, recently revealed he had the condition during an appearance on CBS This Morning. He’s one of about 60,000 people in the U.S. diagnosed with PD each year. More than 10 million people worldwide are living with this progressive neurological disorder, according to the Parkinson’s Disease Foundation. There is no cure. Continue reading
You may have recently heard about the multimillion-dollar donation that Bill Gates and Leonard Lauder made to support research into biomarkers for early detection of Alzheimer’s disease and related dementias.
The Diagnostics Accelerator initiative is part of the Alzheimer’s Drug Discovery Foundation’s (ADDF) effort to speed diagnosis and develop drugs that can prevent, treat, and cure the disease. Lauder was an ADDF co-founder. Continue reading
Photo: Pia Christensen/AHCJNeurologist Dr. Glynnis Zieman, of the Barrow Neurological Institute, answers a question from a Health Journalism 2018 attendee about brain injuries. Mayo Clinic neurologist Dr. Amaal Starling (left) and NPR science correspondent Jon Hamilton (right) also were featured on the panel moderated by NPR’s Scott Hensley.
Doctors and researchers are adapting treatments for brain injuries to recognize individuals’ needs, but still are searching for the right balance of care for a diverse set of patients who have suffered blows to the head, panelists told attendees at one panel during Health Journalism 2018 in Phoenix.
Treating people with possible concussions means providers must assess and manage a wide range of patients, from young athletes and military personnel to domestic violence victims and the elderly, the experts said during the Friday session, “Concussion and brain health: New angles on diagnosis and treatment,” which was moderated by National Public Radio editor Scott Hensley. Continue reading
National Institute of Neurological Disorders and Stroke, National Institutes of Health via Flickr
Male stroke survivors over age 65 may be three times as likely to end up in a nursing home within five years if they lack a caregiver compared with those who have someone to assist them, according to a new study. A similar risk was not seen in female stroke survivors.
The findings suggest that clinicians should remain aware of the critical role of caregivers in helping older adults remain independent. Continue reading